Serial thyroid iodine content in hyperthyroid patients treated with radioiodine

Area of Science:

• Endocrinology
• Nuclear Medicine
• Radiological Sciences

Background:

• Radioactive iodine (I-131) therapy is a common treatment for hyperthyroidism.
• Predicting post-therapy hypothyroidism is crucial for patient management.

Purpose of the Study:

• To determine if initial and serial measurements of thyroidal iodine content can predict hypothyroidism after I-131 therapy.
• To identify patients at high risk of developing hypothyroidism post-treatment.

Main Methods:

• X-ray fluorescent scanning was employed to measure thyroidal iodine content.
• Measurements were taken initially and serially in hyperthyroid patients undergoing I-131 therapy.
• Thyroidal iodine levels were assessed at three months post-therapy to evaluate hypothyroidism risk.

Main Results:

• Thyroidal iodine content decreased rapidly after I-131 therapy, reaching a minimum around three months.
• Patients with less than 2 mg of thyroidal iodine at three months had an 80% chance of early hypothyroidism (within 12 months).
• Patients with greater than 2 mg of thyroidal iodine at three months had only a 14% chance of early hypothyroidism.

Conclusions:

• Serial measurement of thyroidal iodine content using x-ray fluorescent scanning can identify patients at high risk of hypothyroidism.
• This method allows for early identification of individuals likely to develop permanent hypothyroidism following I-131 therapy.